Full donor chimerism in patients undergoing HSCT with a reduced conditioning regimen after one or two alkylating agents: A single center experience

被引：0
|
作者：
Arevalo, C. [1 ]
Paviglianiti, A. [1 ,2 ]
Mussetti, A. [1 ,2 ]
Pena, M. [1 ,2 ]
Hurtado, L. [1 ]
Gonzalez, S. [1 ]
Meriem, K. [1 ]
Parody, R. [3 ]
Sureda, A. [1 ,2 ,4 ]
机构：
[1] Inst Catala Oncol Hosp, Barcelona, Spain
[2] Inst Invest Biomed Bellvitge, Barcelona, Spain
[3] Univ Hosp Virgen Rocio, Seville, Spain
[4] Univ Barcelona, Barcelona, Spain
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P130
引用
收藏
页码：170 / 171
页数：2
相关论文
共 50 条
  • [1] Full Donor Chimerism after Allografts for Myelofibrosis: The Role of Conditioning Regimen
    Chiusolo, Patrizia
    Giammarco, Sabrina
    Lamparelli, Teresa
    Casarino, Lucia
    Rossi, Monica
    Dominietto, Alida
    Raiola, Anna Maria
    Gualandi, Francesca
    Di Grazia, Carmen
    Betti, Silvia
    Sora, Federica
    Rossi, Elena
    Teofili, Luciana
    Sica, Simona
    Bacigalupo, Andrea
    Angelucci, Emanuele
    BLOOD, 2019, 134
  • [2] DONOR CHIMERISM KINETICS IN PEDIATRIC PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING (RIC) WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
    Schneiderman, J.
    Rademaker, A. W.
    Chaudry, S.
    Tse, W.
    Jacobson, D. A.
    Duerst, R.
    Kletzel, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 83 - 83
  • [3] Cardiac complications in patients undergoing a reduced intensity conditioning allogeneic hematopoietic stem cell transplantation (HSCT): A single center experience
    Abidi, M. H.
    Ibrahim, R.
    Mellon-Reppen, S.
    Peres, E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 78 - 79
  • [4] Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen
    Chiusolo, Patrizia
    Bregante, Stefania
    Giammarco, Sabrina
    Lamparelli, Teresa
    Casarino, Lucia
    Dominietto, Alida
    Raiola, Anna Maria
    Metafuni, Elisabetta
    Di Grazia, Carmen
    Gualandi, Francesca
    Sora, Federica
    Laurenti, Luca
    Sica, Simona
    Barosi, Gianni
    Guolo, Fabio
    Rossi, Monica
    Rossi, Elena
    Vannucchi, Alessandro
    Signori, Alessio
    De Stefano, Valerio
    Bacigalupo, Andrea
    Angelucci, Emanuele
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (02) : 234 - 240
  • [5] PERSISTENCE OF FULL DONOR-TYPE PERIPHERAL BLOOD CHIMERISM PREDICTS SURVIVAL ADVANTAGE IN PATIENTS WITH LEUKEMIA AND CHRONIC MYELOID MALIGNANCIES AFTER ALLOGENEIC HSCT USING REDUCED INTENSITY CONDITIONING
    Eggimann, L.
    Bucher, C.
    Girsberger, S.
    Halter, J.
    Gerull, S.
    Tichelli, A.
    Baldomero, H.
    Heim, D.
    Passweg, J.
    Rovo, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S553 - S553
  • [6] Hemopoietic stem cell allogeneic transplantation (HSCT) using a reduced conditioning regimen:: A single centre experience.
    Scimè, R
    Cavallaro, AM
    Santoro, A
    Tringali, S
    Indovina, A
    Marcenò, R
    Pagano, A
    Polizzi, D
    Majolino, I
    BLOOD, 2000, 96 (11) : 357B - 357B
  • [7] Similar outcome in children undergoing unrelated donor HSCT after the use of ATG Fresenius (Grafalon®) or Thymoglobulin in the conditioning regimen
    Krol, Anna
    Owoc-Lempach, Joanna
    Mielcarek, Monika
    Salamonowicz, Malgorzata
    Fraczkiewicz, Jowita
    Janeczko-Czarnecka, Malgorzata
    Stachowiak, Mateusz
    Krzywulski, Aleksander
    Jarmolinski, Tomasz
    Ussowicz, Marek
    Gorczynska, Ewa
    Kalwak, Krzysztof
    BONE MARROW TRANSPLANTATION, 2018, 53 : 722 - 723
  • [8] Successful allogeneic HSCT after treosulfan-based conditioning in two children with PNH: single-center experience
    Pieczonka, A.
    Skalska-Sadowska, J.
    Sobkowiak-Sobierajska, A.
    Wachowiak-Szajdak, K.
    Tomaszewska, R.
    Szczepanski, T.
    Wachowiak, J.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S244 - S244
  • [9] Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience
    Memoli, Mara
    Paviglianiti, Annalisa
    Malard, Florent
    Battipaglia, Giorgia
    Brissot, Eolia
    Mediavilla, Clemence
    Bianchessi, Antonio
    Banet, Anne
    Van de Wyngaert, Zoe
    Ledraa, Tounes
    Belhocine, Ramdane
    Sestili, Simona
    Lapusan, Simona
    Hirsch, Pierre
    Favale, Fabrizia
    Boussaroque, Agathe
    Bonnin, Agnes
    Vekhoff, Anne
    Legrand, Ollivier
    Mohty, Mohamad
    Dulery, Remy
    LEUKEMIA & LYMPHOMA, 2021, 62 (02) : 419 - 427
  • [10] Does Partial Donor Chimerism (PDC) Increase the Risk of Relapse in Pediatric Patients with Leukemia Undergoing Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HSCT)
    Khan, Sana
    Duerst, Reggie E.
    Tse, William T.
    Schneiderman, Jennifer
    Chaudhury, Sonali
    Kletzel, Morris
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S332 - S332
12345